NECC manufactured contaminated drugs earlier as well

In 2003 the FDA planned to shut down the New England Compounding Center (NECC) that recently caused the meningitis outbreak in some states of America. The company produced contaminated Methylprednisolone Acetate injections. Over 400 persons that administered the contaminated steroid injections got fungal meningitis. This illness turned out to be tragic for 39 individuals.
According to a late report released by the House of Energy and Commerce Committee, the meningitis outbreak could have been prevented. The report presented numerous cases linked with the Massachusetts pharmacy that should have been closed by the FDA earlier.
The FDA claimed in 2003 that the Massachusetts pharmacy should not have produced medicines till improving of the situation. But ultimately the FDA didn’t ban manufacture of medications at the NECC. Since the NECC was claimed to be a pharmacy, it should have been monitored by Massachusetts officials. So, the FDA let Massachusetts colleagues to improve the situation. As for Massachusetts officials, they didn’t prohibit manufacture of preparations at once. The NECC continued to produce products. Just Barry Cadden, the owner of the NECC, got reprimand.
Furthermore, the Massachusetts pharmacy was accused of some illegal operations. The company acted inappropriately under its license. Being a pharmacy, the NECC acted as a manufacturer and sent thousands dosages of medicines to hospitals and individual patients.
In 2002 some individuals experienced unusual side reactions after they had used bethamethasone injections manufactured by the Massachusetts pharmacy.
Later some persons that administered methylprednisolone acetate injections produced by the NECC were sickened with bacterial meningitis. Since these persons received full recovery because of antibiotics, the case was forgotten. The NECC was not sanctioned for the tainted injections.
These and even certain other cases manifest that the Massachusetts company should have punished earlier. The company should have been shut down for its illicit and improper actions. But the Massachusetts pharmacy was never sentenced to any serious penalties. As a result, the company continued to manufacture preparations which were dangerous for consumers’ health. Ultimately, the meningitis outbreak caused by contaminated injections of the Massachusetts pharmacy spread to several states and sickened a lot of persons. If the company had been shut down earlier, the contamination with deadly fungal meningitis would not have taken place.